Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
1990 • 1,375 citations
13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia
1986 • 825 citations
Cancer statistics, 1992
1992 • 540 citations
Retinoids in cancer therapy.
1992 • 505 citations
13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin
1992 • 389 citations
Retinoids as preventive and therapeutic anticancer agents (Part I).
1987 • 361 citations
Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
1990 • 351 citations
13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix
1992 • 321 citations
Comprehensive Criteria for Assessing Therapy-Induced Toxicity
1990 • 234 citations
Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60
1987 • 100 citations
Antiproliferative activity of retinoids, interferon α and their combination in five human transformed cell lines
1991 • 75 citations
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial
1988 • 55 citations
Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule
1985 • 47 citations
Modification of radiosensitivity and recovery from X ray damage in vitro by retinoic acid
1989 • 41 citations
Enhancement by retinoic acid and dibutyryl cyclic adenosine 3':5'-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon.
1991 • 36 citations
The combined use of interferon and radiotherapy in cancer management.
1986 • 31 citations
Keynote address: Integration of cytostatic agents and radiation therapy: A different approach to “proliferating” human tumors
1991 • 25 citations
[Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
1985 • 4 citations